4-Aminopyridine Is Superior to 3,4-Diaminopyridine in the Treatment of Patients With Multiple Sclerosis - Concepedia

Concepedia

Publication | Closed Access

4-Aminopyridine Is Superior to 3,4-Diaminopyridine in the Treatment of Patients With Multiple Sclerosis

58

Citations

11

References

1994

Year

Chris H. Polman, F.W. Bertelsmann, Reneé de Waal, H.A.M. van Diemen, Bernard M.J. Uitdehaag, A. C. Van Loenen, J.C. Koetsier

Archives of Neurology

Abstract

Our data suggest that, concerning both efficacy and side effects, 4-aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis.

References

	Year	Citations

Page 1